EDGAR Filing Documents for 0001638599-17-000874

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001638599-17-000874

Filing Date

2017-09-05

Accepted

2017-09-05 16:28:02

Documents

Period of Report

2017-08-31

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	doc4_4883.html	4
1	PRIMARY DOCUMENT	doc4_4883.xml	4	6513
	Complete submission text file	0001638599-17-000874.txt		7964

Mailing Address 21 CORPORATE CIRCLE P O BOX 15098 ALBANY NY 12203-5154

Business Address 21 CORPORATE CIRCLE P O BOX 15098 ALBANY NY 12203-5154 5184640279

ALBANY MOLECULAR RESEARCH INC (Issuer) CIK: 0001065087 (see all company filings)

IRS No.: 141742717 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O SORRENTO THERAPEUTICS, INC. 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121

Business Address

Type: 4 | Act: 34 | File No.: 001-35622 | Film No.: 171069038